BEVACIZUMAB THERAPY FOR THE TREATMENT OF ADULT GLIOBLASTOMA: SYSTEMATIC REVIEW & META-ANALYSIS

被引：0
|
作者：
Kaka, Nagham [1 ]
Hafazalla, Karim [2 ]
Das, Sunit [3 ]
机构：
[1] Natl Univ Ireland Galway, Ancaster Hamilton, ON, Canada
[2] Thomas Jefferson Univ, SKMC, Philadelphia, PA 19107 USA
[3] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-66
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] No Survival Benefit for Patients Undergoing Bevacizumab Therapy for the Treatment of Adult Glioblastoma: A Systematic Review and Meta-Analysis
    Kaka, N.
    Hafazalla, K.
    Samawi, H.
    Simpkin, A.
    Sahgal, A.
    Das, S.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S197 - S197
  • [2] Bevacizumab for recurrent glioblastoma: a systematic review and meta-analysis
    Zhang, T.
    Xin, Q.
    Kang, J-M
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6480 - 6491
  • [3] Bevacizumab treatment for newly diagnosed glioblastoma: Systematic review and meta-analysis of clinical trials
    Fu, Peng
    He, Yun-Song
    Huang, Qin
    Ding, Tao
    Cen, Yong-Cun
    Zhao, Hong-Yang
    Wei, Xiang
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (05) : 833 - 838
  • [4] Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis
    Wang, Huan
    Guo, Jianxin
    Wang, Tianze
    Wang, Kai
    Wu, Zhuojun
    Sun, Tianze
    [J]. BMJ OPEN, 2021, 11 (12):
  • [5] Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
    Kaka, Nagham
    Hafazalla, Karim
    Samawi, Haider
    Simpkin, Andrew
    Perry, James
    Sahgal, Arjun
    Das, Sunit
    [J]. CANCERS, 2019, 11 (11)
  • [6] Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
    Wahyuhadi, Joni
    Immadoel Haq, Irwan Barlian
    Arifianto, Muhammad Reza
    Sulistyono, Bagus
    Meizikri, Rizki
    Rosada, Atika
    Sigit Prakoeswa, Cita Rosita
    Susilo, Rahadian Indarto
    [J]. CANCER CONTROL, 2022, 29
  • [7] Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
    Wahyuhadi, Joni
    Immadoel Haq, Irwan Barlian
    Arifianto, Muhammad Reza
    Sulistyono, Bagus
    Meizikri, Rizki
    Rosada, Atika
    Sigit Prakoeswa, Cita Rosita
    Susilo, Rahadian Indarto
    [J]. CANCER CONTROL, 2022, 29
  • [8] Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
    Wahyuhadi, Joni
    Haq, Irwan Barlian Immadoel
    Arifianto, Muhammad Reza
    Sulistyono, Bagus
    Meizikri, Rizki
    Rosada, Atika
    Prakoeswa, Cita Rosita Sigit
    Susilo, Rahadian Indarto
    [J]. CANCER CONTROL, 2022, 29
  • [9] Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis
    Jian Liu
    Jie-Hui Xu
    Wen Xu
    Guan-Lu Liang
    Ji-Xian Lou
    Yi Wang
    Ji-Quan Wen
    Yong-Bao Cao
    [J]. International Journal of Ophthalmology, 2017, 10 (07) : 1126 - 1133
  • [10] Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis
    Liu, Jian
    Xu, Jie-Hui
    Xu, Wen
    Liang, Guan-Lu
    Lou, Ji-Xian
    Wang, Yi
    Wen, Ji-Quan
    Cao, Yong-Bao
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (07) : 1126 - 1133
12345